Latest News

NightstaRx closes $35 million Series B funding to advance Inherited Retinal Disease pipeline

9th November 2015

All News | Financial News | Spinouts & Startups

Oxford University Innovation spinout NightstaRx Ltd (“Nightstar”), a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, has announced a $35 million Series B financing round.

Launch of ₤50 million UK-China Technology Transfer Fund

22nd October 2015

All News | Financial News

A £50m fund for investing in UK technology for application in China has been launched as part of Chinese President Xi Jinping’s official trip to the UK. Oxford University Innovation is acting as consultant to the fund.

Isis Outcomes at ISPOR 18th Annual European Congress

21st October 2015

All News | Clinical Outcomes

Isis Outcomes will be represented at the ISPOR 18th Annual European Congress to be held in Milan, from November 7th-11th 2015.

Wayra UK and Oxford University Startup Incubator Partner to Accelerate Student Startups

14th October 2015

All News | Spinouts & Startups | Startup Incubator

Spin-out successes recognised in OBN 2015 Awards

2nd October 2015

All News | Spinouts & Startups

Outstanding achievement in the UK Life Sciences sector is celebrated in the annual OBN Awards ceremony. Five spin-outs from Oxford featured in this year’s awards, presented on 1st October.